BIO Bio-Rad Laboratories, Inc.

NYSE
$364.82

Bio-Rad Laboratories, Inc. (BIO) is confirmed to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $2.61 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.3% since its last earnings release on August 4, 2026.

Bio-Rad Laboratories Beat Consensus Estimates
Tuesday, August 4, 2026 · 4:15 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:15 PM ET
Earnings Whisper
-
vs $2.61
Rev est $661.87M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $371.84

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.